Literature DB >> 15694913

Antioxidant and antiinflammatory effect of carvedilol in mononuclear cells of hypertensive patients.

Lorenzo A Calò, Andrea Semplicini, Paul A Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15694913     DOI： 10.1016/j.amjmed.2004.05.030

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure.

Authors:  Hiroki Matsumoto; Takatoshi Kasai; Akihiro Sato; Sayaki Ishiwata; Shoichiro Yatsu; Jun Shitara; Azusa Murata; Takao Kato; Shoko Suda; Yuya Matsue; Masaru Hiki; Atsutoshi Takagi; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2019-05-18       Impact factor: 2.037

2.  Metabolic effects of carvedilol through β-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts.

Authors:  Berna Güven; Zümra Kara; Arzu Onay-Beşikci
Journal:  Br J Pharmacol       Date:  2020-11-15       Impact factor: 8.739

3.  TJ0711, a novel vasodilatory β-blocker, protects SHR rats against hypertension induced renal injury.

Authors:  Juan Yang; Yong Ning; Jun Qiu; Jin-Seng He; Wei Li; Zu-Fu Ma; Ju-Fang Shao; Yue-Qiang Li; Rui Zeng; Meng Zhang; Jia Cheng; Su-Fang Chen; Gang Xu; Cong-Yi Wang; Ying Yao
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

4.  Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I.

Authors:  Shruti Sharma; Xutong Sun; Sanjiv Kumar; Ruslan Rafikov; Angela Aramburo; Gokhan Kalkan; Jing Tian; Imran Rehmani; Suphin Kallarackal; Jeffrey R Fineman; Stephen M Black
Journal:  Free Radic Biol Med       Date:  2012-04-16       Impact factor: 7.376

Review 5.  Use of carvedilol in hypertension: an update.

Authors:  Gastone Leonetti; Colin G Egan
Journal:  Vasc Health Risk Manag       Date:  2012-05-18

6.  Prevention of Skin Carcinogenesis by the Non-β-blocking R-carvedilol Enantiomer.

Authors:  Sherry Liang; Md Abdullah Shamim; Ayaz Shahid; Mengbing Chen; Kristan H Cleveland; Cyrus Parsa; Robert Orlando; Bradley T Andresen; Ying Huang
Journal:  Cancer Prev Res (Phila)       Date:  2021-03-01

7.  Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR.

Authors:  Ahlam M Alhusaini; Laila M Fadda; Abeer M Alanazi; Wedad S Sarawi; Hatun A Alomar; Hanaa M Ali; Iman H Hasan; Rehab Ahmed Ali
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.